Analyst Information for Alder BioPharmaceuticals Inc.

$ 18.87   -0.01 (-0.05%) Volume: 5.42m 4:00 PM EDT Oct 16, 2019
After Hours:  $ 18.87 0.00 (0.00%) Volume: 327.98k 4:57 PM EDT Oct 16, 2019
Consensus Rating Average
Consensus Rating for ALDR is MODERATE BUY
Since many brokers have different rating systems, we maintain a standard system with an assigned numeric value from 1 to 5. Ratings are a translation of brokers' recommendations to the recommendation scale, which ranges from a rating of 1 (a strong buy) to a rating of 5 (a strong sell).
Rating Scale
Strong Buy 1.0 - 1.5
Moderate Buy 1.6 - 2.5
Hold 2.6 - 3.5
Moderate Sell 3.6 - 4.5
Strong Sell 4.6 - 5.0
Consensus Rating Details
Current Average Recommendation 2.17
Previous Average Recommendation 1.73
Change in Average Recommendation 0.44
Number of Analysts Reporting 12
Strong Buy
1.0
Current: 2.17
Previous: 1.73
Change: 0.44
Strong Sell
5.0
Consensus Rating Industry Comparison
Industry: MED-BIOMED/GENE
Number of companies in industry with recommendations 380
Rank Recommendation relative to companies in its industry 327
Ranked 327 in Industry
1380 MED-BIOMED/GENE
Analyst Recommendations
Analysts recommending Strong Buy 5
Analysts recommending Moderate Buy 0
Analysts recommending Hold 7
Analysts recommending Moderate Sell 0
Analysts recommending Strong Sell 0
Vertical Bar Chart
Recommendations History
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 5 7 7 8
Moderate Buy 0 0 0 1
Hold 7 2 2 2
Moderate Sell 0 0 0 0
Strong Sell 0 1 1 1
Mean Rec. 2.17 1.73 1.73 1.69

Copyright © QuoteMedia.   Data delayed at least 15 min. unless otherwise indicated.    RT = Real-Time,  EOD = End Of Day,  PD = Previous Day.   Market Data powered by QuoteMedia. Analyst ratings by Zacks.   Terms of Use.